自己検査市場- 世界の産業規模、シェア、動向、機会および予測、製品別、サンプル別、用途別、流通チャネル別、用途別、地域別、競合別、2020-2030年

自己検査の世界市場は、2024年に112億5,000万米ドルと評価され、2030年には182億5,000万米ドルに達し、CAGR 8.35%で成長すると予測されています。

便利で利用しやすいヘルスケアソリューションに対する消費者の嗜好の高まりに後押しされ、市場は大きく拡大しています。自己検査ツール-妊娠キット、血糖値モニター、コレステロール検査キット、アレルギー検査など-は、個人が自宅で主要な健康指標を追跡することを可能にし、診療所ベースの診断への依存を減らしています。この動向は、特に慢性疾患が世界的に蔓延する中、予防医療が重視されるようになっていることと一致しています。診断技術の進歩とデジタル・ヘルス・プラットフォームの普及は、これらのツールの採用をさらに促進し、自己検査をより正確で、手頃な価格で、使いやすいものにしています。健康意識の高まり、高齢化、規制環境の整備により、消費者中心のヘルスケアへのシフトが加速しており、自己検査は先進経済諸国と新興経済諸国の両方において、現代の健康管理に不可欠な要素となっています。

市場促進要因

高齢化と慢性疾患の増加

主な市場課題

合併症のリスクと手順の制限

主要市場動向

先端技術とイノベーションの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 自己検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品別（キット、デバイス、ストリップ）
  • サンプル（血液、尿、便、その他）
  • 用途別（血圧検査、糖尿病・血糖値検査、コレステロール・トリグリセリド検査、妊娠検査、性感染症検査、尿路感染症検査、がん検査、セリアック病検査、甲状腺検査、トランスアミナーゼ検査、貧血検査、アレルギー検査、その他）
  • 流通チャネル別（オンライン、オフライン）
  • 用途別（使い捨て、再利用可能）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米の自己検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の自己検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域の自己検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の自己検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの自己検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の自己検査市場：SWOT分析

第14章 競合情勢

• Geratherm Medical AG
• Cardinal Health
• OraSure Technologies, Inc
• bioLytical Laboratories Inc
• PRIMA Lab SA
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Bionime Corporation
• Abbott
• Everlywell.

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Self-Testing Market was valued at USD 11.25 billion in 2024 and is projected to reach USD 18.25 billion by 2030, growing at a CAGR of 8.35%. The market is witnessing significant expansion fueled by increasing consumer preference for convenient, accessible healthcare solutions. Self-testing tools-including pregnancy kits, blood glucose monitors, cholesterol test kits, and allergy tests-are enabling individuals to track key health indicators at home, reducing the reliance on clinic-based diagnostics. This trend aligns with the rising emphasis on preventive care, especially as chronic conditions become more prevalent globally. Advancements in diagnostic technologies and the proliferation of digital health platforms have further catalyzed the adoption of these tools, making self-testing more accurate, affordable, and user-friendly. Increased health awareness, aging populations, and supportive regulatory environments are accelerating the shift toward consumer-centric healthcare, positioning self-testing as a vital component of modern health management across both developed and emerging economies.

Key Market Drivers

Aging Population and Rise in Chronic Conditions

The expanding elderly population and growing incidence of chronic illnesses are major factors driving the global self-testing market. The United Nations projects the number of people aged 65 and older will reach 1.6 billion by 2050, doubling from 761 million in 2021. This demographic shift brings greater healthcare needs, especially for ongoing monitoring of conditions such as diabetes, cardiovascular diseases, and hypertension. Self-testing solutions enable elderly individuals to manage these health conditions independently and effectively, reducing their dependency on clinical settings. Chronic disease trends are also evident in younger populations, influenced by sedentary lifestyles, poor diets, and increasing stress levels. This has led to a broader demand for at-home diagnostic tools to monitor parameters like blood pressure, cholesterol, and glucose levels. Additionally, over 73% of noncommunicable disease-related deaths occur in low- and middle-income countries, highlighting a global public health need for accessible and scalable diagnostic tools. The shift toward proactive, at-home monitoring is reinforcing long-term demand for reliable self-testing products.

Key Market Challenges

Risk of Complications and Procedural Limitations

Despite the rising adoption of self-testing kits, procedural limitations and risks of misinterpretation remain key challenges. Users without proper medical guidance may misread results or delay seeking professional care, potentially exacerbating health conditions. Furthermore, the accuracy of some self-tests can vary depending on user compliance with instructions and the type of test administered. Regulatory oversight remains critical to ensure product reliability, but inconsistent regulatory standards across regions can lead to quality disparities in available self-testing options. These limitations can hinder trust in self-testing devices, particularly in lower-income regions or among less technologically adept populations. Addressing these concerns will be vital for continued market expansion and for ensuring that self-testing remains a safe and effective tool within broader healthcare systems.

Key Market Trends

Integration of Advanced Technologies and Innovations

Technological advancements are rapidly reshaping the self-testing landscape, with innovation focused on improving accuracy, usability, and connectivity. Self-testing devices are increasingly incorporating digital readouts, smartphone integration, and cloud-based data storage, enabling users to track and share health metrics seamlessly. Artificial intelligence and machine learning are being explored to enhance test interpretation, particularly in complex areas like allergy testing or cancer screening. Additionally, portable biosensors, wearable health monitors, and app-based testing platforms are gaining traction, particularly among younger, tech-savvy users. These innovations are enhancing consumer confidence and encouraging routine health monitoring. As digital health ecosystems expand globally, the integration of smart self-testing tools into personal health records and telemedicine platforms is becoming a defining trend in the market.

Key Market Players

• Geratherm Medical AG
• Cardinal Health
• OraSure Technologies, Inc
• bioLytical Laboratories Inc
• PRIMA Lab SA
• Becton, Dickinson and Company
• F. Hoffmann-La Roche Ltd
• Bionime Corporation
• Abbott
• Everlywell

Report Scope:

In this report, the Global Self-Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Self-Testing Market, By Product:

• Kits
• Devices
• Strips

Self-Testing Market, By Sample:

• Blood
• Urine
• Stool
• Others

Self-Testing Market, By Application:

• Blood Pressure Test
• Diabetes and Glucose Tests
• Cholesterol and Triglycerides Tests
• Pregnancy Test
• STD / STI Test
• Urinary Tract Infection Test
• Cancer Test
• Celiac Disease Test
• Thyroid Test
• Transaminase Test
• Anemia Test
• Allergy Test
• Others

Self-Testing Market, By Distribution Channel:

• Online
• Offline

Self-Testing Market, By Usage:

• Disposable
• Reusable

Self-Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Self-Testing Market.

Available Customizations:

Global Self-Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Self-Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Kits, Devices, Strips)
  • 5.2.2. By Sample (Blood, Urine, Stool, Others)
  • 5.2.3. By Application (Blood Pressure Test, Diabetes and Glucose Tests, Cholesterol and Triglycerides Tests, Pregnancy Test, STD /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)
  • 5.2.4. By Distribution Channel (Online, Offline)
  • 5.2.5. By Usage (Disposable, Reusable)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Self-Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Sample
  • 6.2.3. By Application
  • 6.2.4. By Distribution Channel
  • 6.2.5. By Usage
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Self-Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Sample
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Distribution Channel
      • 6.3.1.2.5. By Usage
  • 6.3.2. Canada Self-Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Sample
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Distribution Channel
      • 6.3.2.2.5. By Usage
  • 6.3.3. Mexico Self-Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Sample
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Distribution Channel
      • 6.3.3.2.5. By Usage

7. Europe Self-Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Sample
  • 7.2.3. By Application
  • 7.2.4. By Distribution Channel
  • 7.2.5. By Usage
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Self-Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Sample
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Distribution Channel
      • 7.3.1.2.5. By Usage
  • 7.3.2. United Kingdom Self-Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Sample
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Distribution Channel
      • 7.3.2.2.5. By Usage
  • 7.3.3. Italy Self-Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Sample
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Distribution Channel
      • 7.3.3.2.5. By Usage
  • 7.3.4. France Self-Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Sample
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Distribution Channel
      • 7.3.4.2.5. By Usage
  • 7.3.5. Spain Self-Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Sample
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Distribution Channel
      • 7.3.5.2.5. By Usage

8. Asia-Pacific Self-Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Sample
  • 8.2.3. By Application
  • 8.2.4. By Distribution Channel
  • 8.2.5. By Usage
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Self-Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Sample
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Distribution Channel
      • 8.3.1.2.5. By Usage
  • 8.3.2. India Self-Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Sample
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Distribution Channel
      • 8.3.2.2.5. By Usage
  • 8.3.3. Japan Self-Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Sample
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Distribution Channel
      • 8.3.3.2.5. By Usage
  • 8.3.4. South Korea Self-Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Sample
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Distribution Channel
      • 8.3.4.2.5. By Usage
  • 8.3.5. Australia Self-Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Sample
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Distribution Channel
      • 8.3.5.2.5. By Usage

9. South America Self-Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Sample
  • 9.2.3. By Application
  • 9.2.4. By Distribution Channel
  • 9.2.5. By Usage
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Self-Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Sample
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Distribution Channel
      • 9.3.1.2.5. By Usage
  • 9.3.2. Argentina Self-Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Sample
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Distribution Channel
      • 9.3.2.2.5. By Usage
  • 9.3.3. Colombia Self-Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Sample
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Distribution Channel
      • 9.3.3.2.5. By Usage

10. Middle East and Africa Self-Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Sample
  • 10.2.3. By Application
  • 10.2.4. By Distribution Channel
  • 10.2.5. By Usage
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Self-Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Sample
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Distribution Channel
      • 10.3.1.2.5. By Usage
  • 10.3.2. Saudi Arabia Self-Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Sample
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Distribution Channel
      • 10.3.2.2.5. By Usage
  • 10.3.3. UAE Self-Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Sample
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Distribution Channel
      • 10.3.3.2.5. By Usage

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Self-Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Geratherm Medical AG
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Cardinal Health
• 14.3. OraSure Technologies, Inc
• 14.4. bioLytical Laboratories Inc
• 14.5. PRIMA Lab SA
• 14.6. Becton, Dickinson and Company
• 14.7. F. Hoffmann-La Roche Ltd
• 14.8. Bionime Corporation
• 14.9. Abbott
• 14.10.Everlywell.

15. Strategic Recommendations

16. About Us & Disclaimer